Impact of culture medium on linezolid PK/PD activity against Staphylococcus aureus in a Hollow-Fiber infection model simulating cerebrospinal fluid exposure
This study aimed to assess the impact of the culture medium on the effect of linezolid against Staphylococcus aureus using Time-Kill curves (TKC) and Hollow-Fiber infection model (HFIM) by reproducing cerebrospinal fluid (CSF) PK profiles. TKC were performed over 30 h in Mueller-Hinton Broth (MHB), artificial CSF (aCSF) and human CSF (hCSF) at 0, 0.25, 1, 4 x linezolid MIC. Clinical CSF concentrations after 600 or 900 mg q12h and 900 mg q8h were reproduced in HFIM over 96 h in MHB and aCSF. A PK/PD model developed from MHB TKC and HFIM data was combined with hCSF TKC data to predict bacterial counts in HFIM in hCSF. In TKC, bacterial growth was slower in hCSF than MHB. Linezolid was bactericidal in MHB, but only bacteriostatic in hCSF. In aCSF, no growth and no decrease in bacterial counts was observed. In HFIM, bacterial growth was predicted to be also slower in hCSF than MHB. Linezolid at 900 mg q8h was needed to obtain a bactericidal effect in MHB, while 600 mg q12h would be sufficient in hCSF. Despite aCSF renewal in HFIM, no growth and no impact of the treatment was observed whatever linezolid dosing regimen. Bacterial growth and linezolid effect differed between media. MHB overestimated bacterial growth and suggested higher dosing regimen than hCSF, questioning its suitability for central nervous system infections in vitro studies. Using aCSF would be a promising alternative, although its composition requires optimisation to better reproduce bacterial growth and linezolid effect observed in hCSF.
Authors
- Noémie Prébonnaud (ORCID: https://orcid.org/0009-0001-4631-3542)
- Christophe Adier
- Alexia Chauzy (ORCID: https://orcid.org/0000-0001-6443-5888)
- Sandrine Marchand (ORCID: https://orcid.org/0000-0001-5279-6678)
- Claire Dahyot‐Fizelier (ORCID: https://orcid.org/0000-0002-3933-0619)
- Jérémy Moreau
- Isabelle Martin
Institutions
- Inserm (FR)
- Université de Poitiers (FR)
- Centre Hospitalier Universitaire de Poitiers (FR)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.64898/2026.11.16.767216
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- preprint
Funders
- Agence Nationale de la Recherche